A detailed history of Invesco, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Invesco, LLC holds 1,035 shares of ABBV stock, worth $185,472. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,035
Holding current value
$185,472
% of portfolio
0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $169,574 - $206,306
1,035 New
1,035 $204 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $13,760 - $15,497
-100 Reduced 6.97%
1,334 $207 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $191,568 - $221,768
1,434 New
1,434 $214 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Invesco, LLC Portfolio

Follow Invesco, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.